Next Article in Journal
Neurogenic Bladder Physiology, Pathogenesis, and Management after Spinal Cord Injury
Previous Article in Journal
Epidemiological Characteristics and Mortality Risk Factors Comparison in Dialysis and Non-Dialysis CKD Patients with COVID-19—A Single Center Experience
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Saratale et al. Significance of Immune Status of SARS-CoV-2 Infected Patients in Determining the Efficacy of Therapeutic Interventions. J. Pers. Med. 2022, 12, 349

by
Ganesh Dattatraya Saratale
1,
Han-Seung Shin
1,
Surendra Krushna Shinde
2,
Dae-Young Kim
2,
Rijuta Ganesh Saratale
3,
Avinash Ashok Kadam
3,
Manu Kumar
4,
Ali Hassan Bahkali
5,
Asad Syed
5 and
Gajanan Sampatrao Ghodake
2,*
1
Department of Food Science and Biotechnology, Dongguk University-Seoul, 32 Dongguk-ro, Ilsandong-gu, Goyang-si 10326, Gyeonggi-do, Korea
2
Department of Biological and Environmental Science, Dongguk University-Seoul, 32 Dongguk-ro, Ilsandong-gu, Goyang-si 10326, Gyeonggi-do, Korea
3
Research Institute of Biotechnology and Medical Converged Science, Dongguk University-Seoul, 32 Dongguk-ro, Ilsandong-gu, Goyang-si 10326, Gyeonggi-do, Korea
4
Department of Life Science, Dongguk University-Seoul, 32 Dongguk-ro, Ilsandong-gu, Goyang-si 10326, Gyeonggi-do, Korea
5
Department of Botany and Microbiology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia
*
Author to whom correspondence should be addressed.
J. Pers. Med. 2022, 12(6), 967; https://doi.org/10.3390/jpm12060967
Submission received: 23 May 2022 / Accepted: 25 May 2022 / Published: 14 June 2022

Errors in Figures and Table Caption

In the original publication [1], there were mistakes in the legends for Figure 1, Figure 2, and Table 1. We failed to mention the citation number in these legends. The correct legends appear below.
Figure 1. Emerging therapeutic approaches against COVID-19 disease: (1) antibody-based therapeutics against the S protein (either via adoptive transfer of vaccination) to avoid progression of severe infections; (2) application of protease inhibitors against serine protease (TMPRSS2) prevents cleavage of S protein; (3) SRS-CoV-2 virus-specific memory CD8+ T cells from vaccination or earlier infection; (4) a new treatment approach targets the symptoms of cytokine storm, wherein the blood of infected patients is passed through customized filtration columns to capture pro-inflammatory cytokines before the pureblood returns to patients. Adapted and modified from [63].
Figure 2. Cytokine pathogenesis of SARS-CoV-2 infection. Intensive care or appropriate treatment is recommended for hospitalized severe SARS-CoV-2 patients who exhibit elevated levels of biomarkers in blood plasma: alveolar cell (AC), angiotensin-converting enzyme 2 (ACE2), atopic dermatitis (AD), ancestry clusters (AC1-4) granulocyte-macrophage colony–stimulating factor (GM–CSF), granulocyte colony–stimulating factor (G–CSF or GCSF), interleukin (IL), interferon (INF), monocyte chemoattractant protein 1 (MCP1), macrophage inflammatory proteins (MIP1α), natural killer (NK), polymorphonuclear granulocyte (PMN), T-effector cell (TEFF cell), tumor necrosis factor (TNF), regulatory T cell (Treg cell). Adapted and modified from [116].
Table 1. Mechanism of types of drugs and therapies useful in the treatment of SARS-CoV-2-infected patients [3,27,32].
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. These corrections were approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Saratale, G.D.; Shin, H.-S.; Shinde, S.K.; Kim, D.-Y.; Saratale, R.G.; Kadam, A.A.; Kumar, M.; Bahkali, A.H.; Syed, A.; Ghodake, G.S. Significance of Immune Status of SARS-CoV-2 Infected Patients in Determining the Efficacy of Therapeutic Interventions. J. Pers. Med. 2022, 12, 349. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Saratale, G.D.; Shin, H.-S.; Shinde, S.K.; Kim, D.-Y.; Saratale, R.G.; Kadam, A.A.; Kumar, M.; Bahkali, A.H.; Syed, A.; Ghodake, G.S. Correction: Saratale et al. Significance of Immune Status of SARS-CoV-2 Infected Patients in Determining the Efficacy of Therapeutic Interventions. J. Pers. Med. 2022, 12, 349. J. Pers. Med. 2022, 12, 967. https://doi.org/10.3390/jpm12060967

AMA Style

Saratale GD, Shin H-S, Shinde SK, Kim D-Y, Saratale RG, Kadam AA, Kumar M, Bahkali AH, Syed A, Ghodake GS. Correction: Saratale et al. Significance of Immune Status of SARS-CoV-2 Infected Patients in Determining the Efficacy of Therapeutic Interventions. J. Pers. Med. 2022, 12, 349. Journal of Personalized Medicine. 2022; 12(6):967. https://doi.org/10.3390/jpm12060967

Chicago/Turabian Style

Saratale, Ganesh Dattatraya, Han-Seung Shin, Surendra Krushna Shinde, Dae-Young Kim, Rijuta Ganesh Saratale, Avinash Ashok Kadam, Manu Kumar, Ali Hassan Bahkali, Asad Syed, and Gajanan Sampatrao Ghodake. 2022. "Correction: Saratale et al. Significance of Immune Status of SARS-CoV-2 Infected Patients in Determining the Efficacy of Therapeutic Interventions. J. Pers. Med. 2022, 12, 349" Journal of Personalized Medicine 12, no. 6: 967. https://doi.org/10.3390/jpm12060967

APA Style

Saratale, G. D., Shin, H. -S., Shinde, S. K., Kim, D. -Y., Saratale, R. G., Kadam, A. A., Kumar, M., Bahkali, A. H., Syed, A., & Ghodake, G. S. (2022). Correction: Saratale et al. Significance of Immune Status of SARS-CoV-2 Infected Patients in Determining the Efficacy of Therapeutic Interventions. J. Pers. Med. 2022, 12, 349. Journal of Personalized Medicine, 12(6), 967. https://doi.org/10.3390/jpm12060967

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop